Synthetic Biologics, Inc. (AMEX:SYN)

CAPS Rating: 1 out of 5

A development-stage, specialty pharmaceutical company that is developing proprietary, late-stage drug candidates for the treatment of neurologic and fibrotic diseases.

Recs

0
Player Avatar dcuenin (< 20) Submitted: 5/25/2007 6:31:13 AM : Outperform Start Price: $4.07 SYN Score: -48.77

blabla

Featured Broker Partners


Advertisement